Translation and Validation of MESA Questionnaire of Chinese Language Version
Medical, Epidemiologic, and Social Aspects of Aging (MESA) Urinary Incontinence Questionnaire: Translation and Validation of the Chinese Language Version in Women With Urgency-predominant Mixed Urinary Incontinence
1 other identifier
observational
300
1 country
1
Brief Summary
The study is to translate the Medical, Epidemiologic, and Social aspects of Aging (MESA) urinary incontinence questionnaire into a Chinese language version and test the reliability and validity among women with urgency-predominant mixed urinary incontinence. The hypothesis is that the Chinese language version of the MESA questionnaire will have adequate measurement properties (e.g. reliability and validity).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 11, 2019
CompletedFirst Posted
Study publicly available on registry
January 15, 2019
CompletedStudy Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedSeptember 16, 2020
September 1, 2020
3.5 years
January 11, 2019
September 13, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
The criteria validity of MESA questionnaire compared with extended clinical evaluation in deciding predominant components of MUI.
The extended clinical evaluation mainly includes physical examination, 3-day voiding diary, cough stress teat, urinalysis and residual urine volume by ultrasonography.
screening and baseline periods
Secondary Outcomes (4)
The criteria validity of MESA questionnaire compared with International Consultation on Incontinence Questionnaire Short Form (ICIQ SF) in severity assessing among women with urgency-predominant mixed urinary incontinence.
baseline
The criteria validity of MESA questionnaire compared with 3-day voiding diary in severity assessing among women with urgency-predominant mixed urinary incontinence.
baseline
The test-retest reliability of MESA questionnaire
screening and baseline periods
The responsiveness of MESA questionnaire
baseline, week 12
Study Arms (3)
Group 1
Group 1 is anticipated to consist of 300 women with MUI, and the categorization function of MESA questionnaire will be validated among those patients.
Group 2
Group 2 is anticipated to consist of 282 women with urgency-predominant MUI.
Group 3
Group 3 is anticipated to consist of 94 women with urgency-predominant MUI.
Eligibility Criteria
The questionnaire validation is targeted at women with urgency-predominant mixed urinary incontinence.
You may qualify if:
- Female patients diagnosed with MUI in accordance with EAU guideline by history taking, physical examination, laboratory tests and specialist diagnosis;
- Age between 18 and 80 years old;
- At least 4 episodes of UUI in 3-day voiding diary;
- With MUI for at least 3 months, and urgency urinary incontinence dominates more than 50% of the total incontinence episodes in 3-day voiding diary;
- Positive cough test;
You may not qualify if:
- Having pure SUI, pure UUI, overflow UI or neurogenic bladder;
- Uncontrolled urinary tract infection;
- Tumor in urinary system or pelvic organs;
- Pelvic organ prolapse≥degreeⅡ;
- Residual urine volume≥100ml;
- Maximum flow rate\<15ml/s;
- In the past 1 month, receiving treatment of acupuncture or positive medications targeted at incontinence, such as antimuscarinic drugs;
- Underwent anti-incontinence or pelvic organ surgery, including metrectomy;
- Complication of severe diabetes or hypertension;
- Complication of diseases in nervous system that could hamper hypourethral function, such as multiple sclerosis, senile dementia, Parkinson's disease, spinal cord injury, cauda equina nerve injury and multiple system atrophy;
- Severe complications in cardiac, lungs, cerebrum, hepar, renal system, psychonosology and coagulation function, or obvious cognitive disability;
- Installed a cardiac pacemaker;
- Allergic to Solifenacin or with contraindications to antimuscarinic drug, including urinary retention, gastrointestinal peristalsis paralysis, myasthenia gravis, ulcerative colitis and angle-closure glaucoma;
- Allergic to metal or intolerant to the stimulation of electroacupuncture;
- Pregnant or plan to conceive in the future 1 year, or delivery in the past one year.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guang An Men Hospital
Beijing, 100053, China
Related Publications (1)
Sun Y, Liu Y, Su T, Yuan J, Liu Z. Medical, epidemiologic, and social aspects of aging urinary incontinence questionnaire: Study protocol for the translation and validation of a Chinese language version. Medicine (Baltimore). 2019 Nov;98(44):e17719. doi: 10.1097/MD.0000000000017719.
PMID: 31689809DERIVED
Study Officials
- STUDY CHAIR
Zhishun Liu, PhD
Guang An Men Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
January 11, 2019
First Posted
January 15, 2019
Study Start
March 1, 2019
Primary Completion
August 30, 2022
Study Completion
December 30, 2022
Last Updated
September 16, 2020
Record last verified: 2020-09